InvestorsHub Logo
Followers 87
Posts 1159
Boards Moderated 0
Alias Born 09/10/2017

Re: Flyingj post# 24696

Friday, 09/28/2018 6:35:56 PM

Friday, September 28, 2018 6:35:56 PM

Post# of 34625
I haven’t seen a video but I think this is what you are referring to:

Cancer ‘vaccine’ eliminates tumors in mice
https://med.stanford.edu/news/all-news/2018/01/cancer-vaccine-eliminates-tumors-in-mice.html


This is the human trial: (Dynavax (DVAX) is supplying the TLR 9 agonist (SD-101) and Bristol-Myers Squibb (BMY) the anti-OX40 mAb)

TLR9 Agonist SD-101, Anti-OX40 Antibody BMS 986178, and Radiation Therapy in Treating Patients With Low-Grade B-Cell Non-Hodgkin Lymphomas
https://clinicaltrials.gov/ct2/show/NCT03410901

More on OX40
OX40 Agonists: Boosting Cancer Immunotherapy
https://blog.crownbio.com/ox40-ox40l-immune-co-stimulators

These companies are all testing anti-OX40 mAbs: Astrazeneca (MEDI0562), Agenus (INCAGN1949), Bristol-Myers Squibb (BMS-986178), Genentech (MOXR0916), GlaxoSmithKline (GSK3174998), Pfizer (PF-04518600), and Roche (RG7888)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News